Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MYCN gain and MYCN amplification in a stage 4S neuroblastoma.
Noguera R, Cañete A, Pellín A, Ruiz A, Tasso M, Navarro S, Castel V, Llombart-Bosch A. Noguera R, et al. Among authors: canete a. Cancer Genet Cytogenet. 2003 Jan 15;140(2):157-61. doi: 10.1016/s0165-4608(02)00677-5. Cancer Genet Cytogenet. 2003. PMID: 12645655
A comparison of current neuroblastoma chemotherapeutics.
Castel V, Cañete A. Castel V, et al. Among authors: canete a. Expert Opin Pharmacother. 2004 Jan;5(1):71-80. doi: 10.1517/14656566.5.1.71. Expert Opin Pharmacother. 2004. PMID: 14680437 Review.
[Neuroblastoma].
Castel V, Cañete A, Noguera R, Navarro S, Oltra S; Grupo Español de Neuroblastoma (SEOP). Castel V, et al. Among authors: canete a. Clin Transl Oncol. 2005 Apr;7(3):133-45. doi: 10.1007/BF02708748. Clin Transl Oncol. 2005. PMID: 15899223 Review. Spanish. No abstract available.
MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors.
Grau E, Oltra S, Martínez F, Orellana C, Cañete A, Fernández JM, Hernández-Martí M, Castel V. Grau E, et al. Among authors: canete a. J Cancer Res Clin Oncol. 2009 Apr;135(4):523-31. doi: 10.1007/s00432-008-0484-1. Epub 2008 Sep 27. J Cancer Res Clin Oncol. 2009. PMID: 18820946
Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification.
De Bernardi B, Gerrard M, Boni L, Rubie H, Cañete A, Di Cataldo A, Castel V, Forjaz de Lacerda A, Ladenstein R, Ruud E, Brichard B, Couturier J, Ellershaw C, Munzer C, Bruzzi P, Michon J, Pearson AD. De Bernardi B, et al. Among authors: canete a. J Clin Oncol. 2009 Mar 1;27(7):1034-40. doi: 10.1200/JCO.2008.17.5877. Epub 2009 Jan 26. J Clin Oncol. 2009. PMID: 19171711 Clinical Trial.
Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience.
Canete A, Gerrard M, Rubie H, Castel V, Di Cataldo A, Munzer C, Ladenstein R, Brichard B, Bermúdez JD, Couturier J, de Bernardi B, Pearson AJ, Michon J. Canete A, et al. J Clin Oncol. 2009 Mar 1;27(7):1014-9. doi: 10.1200/JCO.2007.14.5839. Epub 2009 Jan 26. J Clin Oncol. 2009. PMID: 19171715 Clinical Trial.
194 results